Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-044613
Filing Date
2024-10-31
Accepted
2024-10-31 17:27:11
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 s-3resale.htm S-3 265381
2 EX-FILING FEES resaleexhibit107.htm EX-FILING FEES 43245
3 EX-5.1 a51opinionlettergoodwinres.htm EX-5.1 7044
4 EX-23.1 ex231kpmgconsentresale.htm EX-23.1 2562
5 goodwinlogo.jpg GRAPHIC 10933
6 image_0a.jpg GRAPHIC 5553
7 image_4.jpg GRAPHIC 269
8 kpmglogo.jpg GRAPHIC 2459
9 kpmgsignature.jpg GRAPHIC 9503
  Complete submission text file 0001628280-24-044613.txt   359411
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-282934 | Film No.: 241416287
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)